Does maternal-fetal transfer of creatine occur in pregnant sheep?

Syed Baharom, Robert De Matteo, Stacey Ellery, Paul Della Gatta, Clinton R. Bruce, Greg M. Kowalski, Nadia Hale, Hayley Dickinson, Richard Harding, David Walker, Rodney J. Snow

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Our aim was to determine the disposition of creatine in ovine pregnancy and whether creatine is transferred across the placenta from mother to fetus. Pregnant ewes received either 1) a continuous intravenous infusion of creatine monohydrate or saline from 122 to 131 days gestation, with maternal and fetal arterial blood and amniotic fluid samples collected daily for creatine analysis and fetal tissues collected at necropsy at 133 days for analysis of creatine content, or 2) a single systemic bolus injection of [13C]creatine monohydrate at 130 days of gestation, with maternal and fetal arterial blood, uterine vein blood, and amniotic fluid samples collected before and for 4 h after injection and analyzed for creatine, creatine isotopic enrichment, and guanidinoacetic acid (GAA; precursor of creatine) concentrations. Presence of the creatine transporter-1 (SLC6A8) and L-arginine:glycine amidinotransferase (AGAT; the enzyme synthesizing GAA) proteins were determined by Western blots of placental cotyledons. The 10-day creatine infusion increased maternal plasma creatine concentration three- to fourfold (P < 0.05) without significantly changing fetal arterial, amniotic fluid, fetal tissues, or placental creatine content. Maternal arterial 13C enrichment was increased (P < 0.05) after bolus [13C]creatine injection without change of fetal arterial 13C enrichment. SLC6A8 and AGAT proteins were identified in placental cotyledons, and GAA concentration was significantly higher in uterine vein than maternal artery plasma. Despite the presence of SLC6A8 protein in cotyledons, these results suggest that creatine is not transferred from mother to fetus in near-term sheep and that the ovine utero-placental unit releases GAA into the maternal circulation.

Original languageEnglish
Pages (from-to)E75-E83
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume313
Issue number1
DOIs
Publication statusPublished - 2017

Keywords

  • Creatine
  • Fetus
  • Guanidinoacetic acid
  • Placenta
  • Pregnancy

Cite this

Baharom, Syed ; De Matteo, Robert ; Ellery, Stacey ; Della Gatta, Paul ; Bruce, Clinton R. ; Kowalski, Greg M. ; Hale, Nadia ; Dickinson, Hayley ; Harding, Richard ; Walker, David ; Snow, Rodney J. / Does maternal-fetal transfer of creatine occur in pregnant sheep?. In: American Journal of Physiology - Endocrinology and Metabolism. 2017 ; Vol. 313, No. 1. pp. E75-E83.
@article{c7500278f47749de817bb6afc63a8c1b,
title = "Does maternal-fetal transfer of creatine occur in pregnant sheep?",
abstract = "Our aim was to determine the disposition of creatine in ovine pregnancy and whether creatine is transferred across the placenta from mother to fetus. Pregnant ewes received either 1) a continuous intravenous infusion of creatine monohydrate or saline from 122 to 131 days gestation, with maternal and fetal arterial blood and amniotic fluid samples collected daily for creatine analysis and fetal tissues collected at necropsy at 133 days for analysis of creatine content, or 2) a single systemic bolus injection of [13C]creatine monohydrate at 130 days of gestation, with maternal and fetal arterial blood, uterine vein blood, and amniotic fluid samples collected before and for 4 h after injection and analyzed for creatine, creatine isotopic enrichment, and guanidinoacetic acid (GAA; precursor of creatine) concentrations. Presence of the creatine transporter-1 (SLC6A8) and L-arginine:glycine amidinotransferase (AGAT; the enzyme synthesizing GAA) proteins were determined by Western blots of placental cotyledons. The 10-day creatine infusion increased maternal plasma creatine concentration three- to fourfold (P < 0.05) without significantly changing fetal arterial, amniotic fluid, fetal tissues, or placental creatine content. Maternal arterial 13C enrichment was increased (P < 0.05) after bolus [13C]creatine injection without change of fetal arterial 13C enrichment. SLC6A8 and AGAT proteins were identified in placental cotyledons, and GAA concentration was significantly higher in uterine vein than maternal artery plasma. Despite the presence of SLC6A8 protein in cotyledons, these results suggest that creatine is not transferred from mother to fetus in near-term sheep and that the ovine utero-placental unit releases GAA into the maternal circulation.",
keywords = "Creatine, Fetus, Guanidinoacetic acid, Placenta, Pregnancy",
author = "Syed Baharom and {De Matteo}, Robert and Stacey Ellery and {Della Gatta}, Paul and Bruce, {Clinton R.} and Kowalski, {Greg M.} and Nadia Hale and Hayley Dickinson and Richard Harding and David Walker and Snow, {Rodney J.}",
year = "2017",
doi = "10.1152/ajpendo.00450.2016",
language = "English",
volume = "313",
pages = "E75--E83",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "1522-1555",
publisher = "American Physiological Society",
number = "1",

}

Does maternal-fetal transfer of creatine occur in pregnant sheep? / Baharom, Syed; De Matteo, Robert; Ellery, Stacey; Della Gatta, Paul; Bruce, Clinton R.; Kowalski, Greg M.; Hale, Nadia; Dickinson, Hayley; Harding, Richard; Walker, David; Snow, Rodney J.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 313, No. 1, 2017, p. E75-E83.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Does maternal-fetal transfer of creatine occur in pregnant sheep?

AU - Baharom, Syed

AU - De Matteo, Robert

AU - Ellery, Stacey

AU - Della Gatta, Paul

AU - Bruce, Clinton R.

AU - Kowalski, Greg M.

AU - Hale, Nadia

AU - Dickinson, Hayley

AU - Harding, Richard

AU - Walker, David

AU - Snow, Rodney J.

PY - 2017

Y1 - 2017

N2 - Our aim was to determine the disposition of creatine in ovine pregnancy and whether creatine is transferred across the placenta from mother to fetus. Pregnant ewes received either 1) a continuous intravenous infusion of creatine monohydrate or saline from 122 to 131 days gestation, with maternal and fetal arterial blood and amniotic fluid samples collected daily for creatine analysis and fetal tissues collected at necropsy at 133 days for analysis of creatine content, or 2) a single systemic bolus injection of [13C]creatine monohydrate at 130 days of gestation, with maternal and fetal arterial blood, uterine vein blood, and amniotic fluid samples collected before and for 4 h after injection and analyzed for creatine, creatine isotopic enrichment, and guanidinoacetic acid (GAA; precursor of creatine) concentrations. Presence of the creatine transporter-1 (SLC6A8) and L-arginine:glycine amidinotransferase (AGAT; the enzyme synthesizing GAA) proteins were determined by Western blots of placental cotyledons. The 10-day creatine infusion increased maternal plasma creatine concentration three- to fourfold (P < 0.05) without significantly changing fetal arterial, amniotic fluid, fetal tissues, or placental creatine content. Maternal arterial 13C enrichment was increased (P < 0.05) after bolus [13C]creatine injection without change of fetal arterial 13C enrichment. SLC6A8 and AGAT proteins were identified in placental cotyledons, and GAA concentration was significantly higher in uterine vein than maternal artery plasma. Despite the presence of SLC6A8 protein in cotyledons, these results suggest that creatine is not transferred from mother to fetus in near-term sheep and that the ovine utero-placental unit releases GAA into the maternal circulation.

AB - Our aim was to determine the disposition of creatine in ovine pregnancy and whether creatine is transferred across the placenta from mother to fetus. Pregnant ewes received either 1) a continuous intravenous infusion of creatine monohydrate or saline from 122 to 131 days gestation, with maternal and fetal arterial blood and amniotic fluid samples collected daily for creatine analysis and fetal tissues collected at necropsy at 133 days for analysis of creatine content, or 2) a single systemic bolus injection of [13C]creatine monohydrate at 130 days of gestation, with maternal and fetal arterial blood, uterine vein blood, and amniotic fluid samples collected before and for 4 h after injection and analyzed for creatine, creatine isotopic enrichment, and guanidinoacetic acid (GAA; precursor of creatine) concentrations. Presence of the creatine transporter-1 (SLC6A8) and L-arginine:glycine amidinotransferase (AGAT; the enzyme synthesizing GAA) proteins were determined by Western blots of placental cotyledons. The 10-day creatine infusion increased maternal plasma creatine concentration three- to fourfold (P < 0.05) without significantly changing fetal arterial, amniotic fluid, fetal tissues, or placental creatine content. Maternal arterial 13C enrichment was increased (P < 0.05) after bolus [13C]creatine injection without change of fetal arterial 13C enrichment. SLC6A8 and AGAT proteins were identified in placental cotyledons, and GAA concentration was significantly higher in uterine vein than maternal artery plasma. Despite the presence of SLC6A8 protein in cotyledons, these results suggest that creatine is not transferred from mother to fetus in near-term sheep and that the ovine utero-placental unit releases GAA into the maternal circulation.

KW - Creatine

KW - Fetus

KW - Guanidinoacetic acid

KW - Placenta

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85021862599&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00450.2016

DO - 10.1152/ajpendo.00450.2016

M3 - Article

VL - 313

SP - E75-E83

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 1522-1555

IS - 1

ER -